Publication | Open Access
TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis
55
Citations
45
References
2018
Year
Lung MetastasisTlr9 Agonist EnhancesMedicineImmunologyAblation-induced Ctl ResponsesBronchial NeoplasmCancer TreatmentLung CancerOncologyRadiation OncologyTumor MicroenvironmentTumor BiologyCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1